Assessment of depression prevalence and its relation with interleukin 18 one year after renal transplantation

American Journal of Therapeutics

Volumn 23, Issue 6, 2016, Pages e1579-e1585

  Sahraei, Zahra ^a   Eshraghi, Azadeh ^b   Eslami, Neda ^c   Mehdizadeh, Mona ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Depression; Interleukin 18; Renal transplantation

Indexed keywords

BIOLOGICAL MARKER; CREATININE; INTERLEUKIN 18;

ACUTE KIDNEY INJURY; ADULT; AGE; BLOOD; DEPRESSION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; TIME FACTOR;

ACUTE KIDNEY INJURY; ADULT; AGE FACTORS; BIOMARKERS; CREATININE; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-18; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TRANSPLANT RECIPIENTS;

EID: 84995803026     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000192     Document Type: Article

References (45)

1. Baines LS, Joseph JT, Jindal RM. Prospective randomized study of individual and group psychotherapy versus controls in recipients of renal transplants. Kidney Int. 2004;65:1937-1942.
2. Cameron JI, Whiteside C, Katz J, et al. Differences in quality of life across renal replacement therapies: a metaanalytic comparison. Am J Kidney Dis. 2000;35:629-637.
3. Rocha G, Poli de Figueiredo CE, d'Avila D, et al. Depressive symptoms and kidney transplant outcome. Transplant Proc. 2001;33:3424.
4. Akman B, Özdemir FN, Sezer S, et al. Depression levels before and after renal transplantation. Transplant Proc. 2004;36:111-113.
5. Szeifert L, Molnar MZ, Ambrus C, et al. Symptoms of depression in kidney transplant recipients: a crosssectional study. Am J Kidney Dis. 2010;55:132-140.
6. Dobbels F, Skeans MA, Snyder JJ, et al. Depressive disorder in renal transplantation: an analysis of medicare claims. Am J Kidney Dis. 2008;51:819-828.
7. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993;55:51-56.
8. Jindal RM, Neff RT, Abbott KC, et al. Association between depression and nonadherence in recipients of kidney transplants: analysis of the United States renal data system. Transplant Proc. 2009;41:3662-3666.
9. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-2107.
10. Alavi NM, Aliakbarzadeh Z, Sharifi K. Depression, anxiety, activities of daily living, and quality of life scores in patients undergoing renal replacement therapies. Transplant Proc. 2009;41:3693-3696.
11. Tsunoda T, Yamashita R, Kojima Y, et al. Risk factors for depression after kidney transplantation. Transplant Proc. 2009;42:1679-1681.
12. Dinarello CA. Interleukin-18. Methods. 1999;19;121-132.
13. Cerri AP, Arosio B, Viazzoli C, et al. 308(G/A) TNFalpha gene polymorphism and risk of depression late in the life. Arch Gerontol Geriatr. 2009;49:29-34.
14. Cerri AP, Arosio B, Viazzoli C, et al. The-308 (G/A) single nucleotide polymorphism in the TNF-αlpha gene and the risk of major depression in the elderly. Int J Geriatr Psychiatry. 2010;25:219-223.
15. Traks T, Koido K, Eller T, et al. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Med Genet. 2009;16:111.
16. Roque S, Correia-Neves M, Mesquita AR, et al. Interleukin-10: a key cytokine in depression? Cardiovasc Psychiatry Neurol. 2009;2009:187894.
17. Haastrup E, Bukh JD, Bock C, et al. Promoter variants in IL18 are associated with onset of depression in patients previously exposed to stressful-life events. J Affect Disord. 2012;136:134-138.
18. Merendino RA, Di Rosa AE, Di Pasquale G, et al. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm. 2002;11: 265-267.
19. Kokai M, Kashiwamura S, Okamura H, et al. Plasmainterleukin-18 levels in patients with psychiatric disorders. J Immunother. 2002;25(Suppl 1):68-71.
20. Zelle DM, Dorland HF, Rosmalen JG, et al. Impact of depression on long-term outcome after renal transplantation: a prospective cohort study. Transplantation. 2012; 94:1033-1040.
21. Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81:247-255.
22. Jonsson P, Stahl ML, Ohlesson K. Extracorporeal circulation causes release of neutrophilge latinase-associated lipocalin (NGAL). Mediators Inflamm. 1999;8:169-171.
23. Takahashi HK, Watanabe T, Yokoyama A. Cimetidine induces interleukin-18 production through H2-agonist activity in monocytes. Mol Pharmacol. 2006;70:450-453.
24. Alboni S, Cervia D, Sugama S, et al. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9.
25. Kristo C, Godang K, Ueland T, et al. Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome. Eur J Endocrinol. 2002;146:389-395.
26. Favilli F, Anzilotti C, Martinelli L, et al. IL-18 activity in systemic lupus erythematosus. Ann NY Acad Sci. 2009; 1173:301-309.
27. Ueda1 T, Takeyama Y, Yasuda1 T, et al. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol. 2006;41:158-165.
28. Grombmyer SR, Lin E, Lowry SF, et al. Elevation of IL-18 in human sepsis. J Clin Immunol. 2000;20:212-215.
29. Elkholy MT, Ewees IR. Neutrophil gelantinase associated lipocalin (NGAL) as a biomarker of painful vasoocclusive crisis in sickle cell disease (SCD). Med J Cairo Univ. 2009;77:467-471.
30. Johnston O, O'kelly P, Spencer S, et al. Reduced graft function (with or without dialysis) vs immediate graft function-a comparison of long-term renal allograft survival. Nephrol Dial Transplant. 2006;21:2270-2274.
31. Kidney Disease Improving Global outcomes (KDiGO) Acute Kidney Injury Work Group. KDiGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2: 1-138.
32. Beck AT, Ward C, Mendelson M. Beck depression inventory (BDi). Arch Gen Psychiatry. 1961;4:561-571.
33. Ghassemzadeh H, Mojtabai R, Karamghadiri N, et al. Psychometric properties of a Persian-language version of the Beck Depression Inventory-Second edition: BDiIIPERSIAN. Depress Anxiety. 2005;21:185-192.
34. Bossu P, Salani F, Cacciari C, et al. Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res. 2009;6:163-170.
35. Prossin AR, Koch AE, Campbell PL, et al. Association of plasma interleukin-18 levels with emotion regulation and opioid neurotransmitter function in major depression and healthy volunteers. Biol Psychiatry. 2011;69:808-812.
36. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9: 46-56.
37. Russo S, Kema IP, Fokkema MR, et al. Tryptophan as a link between psychopathology and somatic states. Psychosom Med. 2003;65:665.
38. Christmas DM, Potokar J, Davies SJ. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat. 2011;7:431.
39. Gangemi S, Mallamace A, Minciullo PL, et al. Involvement of interleukin-18 in patients on maintenance haemodialysis. Am J Nephrol. 2002;22:417-421.
40. Chiang CK, Hsu SP, Pai MF, et al. Interleukin-18 is a strong predictor of hospitalization in haemodialysis patients. Nephrol Dial Transplant. 2004;19:2810-2815.
41. Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005;67:1216-1233.
42. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet. 2000; 356:147-152.
43. Fried L, Solomon C, Shlipak M, et al. In?ammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J Am Soc Nephrol. 2004;15: 3184-3191.
44. Schulz R, Drayer RA, Rollman BL. Depression as a risk factor for non-suicide mortality in the elderly. Biol Psychiatry. 2002;52:205-225.
45. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306:1241-1249.